Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Sandhofer, M; Hanke, CW; Habbema, L; Podda, M; Rapprich, S; Schmeller, W; Herbst, K; Anderhuber, F; Pilsl, U; Sattler, G; Sandhofer, M; Moosbauer, W; Sattler, S; Schauer, P; Faulhaber, J; Maier, S; Barsch, M; Mindt, S; Halk, AB.
Prevention of Progression of Lipedema With Liposuction Using Tumescent Local Anesthesia: Results of an International Consensus Conference.
Dermatol Surg. 2020; 46(2): 220-228.
Doi: 10.1097/DSS.0000000000002019
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Anderhuber Friedrich
- Pilsl Ulrike
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Lipedema is a chronic, progressive disorder of subcutaneous adipose tissue that usually affects the lower extremities of women. Also known as "two-body syndrome," the fat accumulations in lipedema are unsightly and painful. The disorder is well-known in Europe but is largely unrecognized and underdiagnosed in the United States. To hold the First International Consensus Conference on Lipedema with the purpose of reviewing current European guidelines and the literature regarding the long-term benefits that have been reported to occur after lymph-sparing liposuction for lipedema using tumescent local anesthesia. International experts on liposuction for lipedema were convened as part of the First International Congress on Lipedema in Vienna, Austria, June 9 to 10, 2017. Multiple studies from Germany have reported long-term benefits for as long as 8 years after liposuction for lipedema using tumescent local anesthesia. Lymph-sparing liposuction using tumescent local anesthesia is currently the only effective treatment for lipedema.